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Background: Mortality amenable to health-care services (‘amenable mortality’) has been defined as “premature
deaths that should not occur in the presence of timely and effective health care” and as “conditions for which
effective clinical interventions exist.” We analyzed the regional variability in health-care services using amenable
mortality as a performance indicator. Convergent validity was examined against other indicators, such as health
expenditure, GDP per capita, life expectancy at birth, disability-free life expectancy at age 15, number of diagnostic
and laboratory tests per 1,000 inhabitants, and the prevalence of cancer and cardiovascular diseases.
Methods: Amenable mortality rate was calculated as the average annual number of deaths in the population aged
0–74 years per 100,000 inhabitants, and it was then stratified by gender and region. Data were drawn from national
mortality statistics for the period 2006–08.
Results: During the study period (2006–08), the age-standardized death rate (SDR) amenable to health-care services
in Italy was 62.6 per 100,000 inhabitants: 66.0 per 100,000 for males and 59.1 per 100,000 for females. Significant
regional variations ranged from 54.1 per 100,000 inhabitants in Alto Adige to 76.3 per 100,000 in Campania.
Regional variability in SDR was examined separately for male and females. The variability proved to be statistically
significant for both males and females (males: Q-test = 638.5, p < 0.001; females: Q-test = 700.1, p < 0.001).
However, among men, we found a clear-cut divide in SDR values between Central and Southern Italy; among
women, this divide was less pronounced. Amenable mortality was negatively correlated with life expectancy at
birth for both genders (male: r = −0.64, p = 0.002; female: r = −0.88, p <0.001) and with disability-free life
expectancy at age 15 (male: r = −0.70, p <0.001; female: r = −0.67, p <0.001). Amenable mortality displayed a
statistically significant negative relationship with GDP per capita, the quantity of diagnostic and laboratory tests
per 1,000 inhabitants, and the prevalence of cancer.
Conclusions: Amenable mortality shows a wide variation across Italian regions and an inverse relationship with
life expectancy and GDP per capita, as expected.
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The performance of health-care systems in terms of
maximizing population health has been a major concern
of policy makers [1-5]. Explicit frameworks defining the
goals of a health system, against specific outcomes and
performance indicators are required [6].* Correspondence: mariapia.fantini@unibo.it
†Equal contributors
1Department of Medicine and Public Health, Alma Mater Studiorum,
University of Bologna, Bologna 40126, Italy
Full list of author information is available at the end of the article
© 2012 Fantini et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orIn recent years, the concept of amenable mortality has
been used as a proxy for performance of health-care sys-
tems by Nolte and McKee [7-9] and Tobias and Yeh
[10]. These authors took the term “amenable mortality”,
developed by European researchers in the 1980s and
1990s [8,11], to assess the quality and performance of
health systems over time [8,9].
Mortality amenable to health-care services (hereafter
amenable mortality) has been defined as “premature
deaths that should not occur in the presence of timely
and effective health care” [9] and as “conditions forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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might be expected, the correlation between amenable
mortality rates and life expectancy is high since amen-
able mortality is, by definition, included in overall mor-
tality, even if amenable mortality rates may differ in
countries with similar life expectancy at birth [11]. Fur-
thermore, amenable mortality also correlates with
disability-adjusted life expectancy with better face valid-
ity [7].
Nolte and McKee carried out a comprehensive study
[9] of amenable mortality in 19 Organization for Eco-
nomic Co-operation and Development (OECD) coun-
tries between 1997–98 and 2002–03, and they found a
clear decline in amenable mortality in all the countries
investigated. In that study, Italy showed a reduction in
amenable mortality from 88.7 per 100,000 (1997–98) to
74.0 per 100,000 (2002), and in 2002 it ranked fifth
among the 19 OECD countries.
Another recent study [11] has provided estimates of
amenable mortality for a large set (31) of OECD countries,
and it assessed the sensitivity of this indicator by compar-
ing the two widely used lists (those of Nolte and McKee
[9] and Tobias and Yeh [10]). Results published by the
OECD [11] show that in 2007 age-standardized amenable
mortality rates ranged from 60 to 200 deaths per 100,000
in the OECD countries. The above two lists provided simi-
lar results for most countries. Eastern European countries
and Mexico had the highest rates; Japan, France, Italy,
Sweden, and Iceland had the lowest ones. Mortality rates
for Italy (2006 data) ranged from 65 deaths per 100,000
(Nolte and McKee’s list) to 71 per 100,000 (Tobias and
Yeh’s list). Italy ranked third in both lists.Piedmont
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Figure 1 Forest plot showing the regional SDRs (with 95% confidence
years 2006–08.Amenable mortality is also a useful indicator for meas-
uring the performance of health-care systems. As a strat-
egy to deal with shrinking resources while increasing
local government accountability, efficiency, quality, and
innovation in the health-care sector, the process of
decentralization of powers from national to regional
levels has been widely implemented across European
health-care systems [12]. Therefore, the distribution of
powers between central and regional levels as well as
their respective roles in funding and providing health-
care services is crucial.
In Italy, the central government is responsible for na-
tional health planning and annual funding. It also has
the exclusive power to set the so-called essential levels
of care (Livelli Essenziali di Assistenza; LEAs), an expli-
cit, publicly funded health-benefit package to which all
citizens are entitled. Regions have virtually exclusive re-
sponsibility for the organization and administration of
publicly financed health care [13]. Therefore, monitoring
the performance of regional levels of the health-care sys-
tem has become of increasing interest in policy decision
making.
The aim of this study was twofold. The first was to
analyze the regional variability in health-care services
using amenable mortality as a performance indicator.
The second was to examine the convergent validity of
amenable mortality against other indicators, such as
health expenditure, GDP per capita, life expectancy at
birth, disability-free life expectancy at age 15, number
of diagnostic and laboratory tests per 1,000 inhabi-
tants, and the prevalence of cancer and cardiovascular
diseases.65 70 75 80
with 95%CIs (x100,000)
intervals [CIs]) in relation to the Italian average (red line) for the
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Figure 2 Geographical distribution of regional SDRs in Italy for the years 2006–08.
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A cross-sectional study was carried out on individual
data from national mortality statistics for the period
2006–08 using data from the Italian National Institute
of Statistics (ISTAT), where the causes of death are
coded using the ICD-10 classification. Nolte and
McKee [7-9] and Tobias and Yeh [10] prepared two
different lists of causes of death amenable to health-
care [7]. These two lists were used by OECD to gener-
ate estimates of amenable mortality for 31 countries
[11]. After reviewing the two sets of estimates of
amenable mortality for OECD countries provided by
Nolte and McKee’s and Tobias and Yeh’s lists, we
decided to choose Nolte and McKee’s list because it
offers on average more conservative figures.
Amenable mortality rate was calculated as the average
annual number of deaths over the population aged
0–74 years per 100,000 inhabitants, and it was then
stratified by gender, region (19 regions and the two
autonomous provinces of Trentino and Alto Adige) and
10 disease categories defined by Gay et al. in an OECD
report (see Additional file 1: Table S1) [11]. We com-
puted age-standardized death rates (SDRs) using the
2005 OECD population as the standard population.
Forest plots and Cochrane’s Q-test were used to com-
pare the regional SDRs with the Italian average. We
computed 95% confidence intervals using Chiang’s nor-
mal approximation to Poisson distribution [14]. RegionalPiedmont
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Figure 3 Forest plots showing the regional SDRs (with 95% CIs) by ge
2006–08.SDRs for specific disease categories were plotted in rela-
tion to the Italian average using radar graphs.
We examined the relationship between amenable mor-
tality and life expectancy at birth as well as disability-
free life expectancy at age 15, using linear regression
models stratified by gender as suggested in the literature
[7,11]. Disability-free life expectancy at age 15 indicates
the expected number of healthy life-years. Linear regres-
sion models were also used to analyze the relationship
between regional SDRs and public health expenditure
per capita, GDP per capita, number of diagnostic and la-
boratory tests per 1,000 inhabitants, cancer prevalence,
and prevalence of cardiovascular diseases.
Disability-free life expectancy, cancer prevalence, and
prevalence of cardiovascular diseases were drawn from
the ISTAT Multiscope National Survey [15]. Public
health expenditure and GDP per capita were drawn from
Rapporto Osservasalute for 2011 [16]. The number of
diagnostic and laboratory tests was taken from the Min-
istry of Health data on health-care activities [17].
Results are provided by regions. Northern Italy
includes Piedmont, Aosta Valley, Lombardy, Alto Adige,
Trentino, Veneto, Friuli-Venezia Giulia, Liguria and
Emilia-Romagna; Central Italy includes Tuscany, Umbria,
Marche and Lazio; Southern Italy includes Abruzzo,
Molise, Campania, Puglia, Basilicata, Calabria, Sicily, and
Sardinia. Statistical analyses were performed using Stata
11 [18].Piedmont
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Differences in amenable mortality among Italian regions
During the study period (2006–08), the SDR in Italy
was 62.6 per 100,000 inhabitants: 66.0 per 100,000 for
males and 59.1 per 100,000 for females. Figures 1 and 2
shows the regional distribution of SDRs. A statistically
significant regional variation was found, with a range
from 54.1 per 100,000 in Alto Adige to 76.3 per
100,000 in Campania. Specifically, results indicate that
for five regions (Piedmont, Lazio, Campania, Calabria,
and Sicily), SDRs were statistically significantly higher
than the national average, whereas for six regions
(Aosta Valley, Friuli-Venezia Giulia, Abruzzo, Molise,
Basilicata, and Sardinia) the rates did not differFigure 4 a. Radar plot showing the regional SDRs for cancers in relat
b. Radar plot showing the regional SDRs for cardiovascular diseases in relatstatistically significantly from the national average. Fi-
nally, in ten regions (Lombardy, Trentino, Alto Adige,
Veneto, Liguria, Emilia-Romagna, Tuscany, Umbria,
Marche, and Puglia), SDRs were statistically signifi-
cantly lower than the national average. Southern Italy
generally had higher SDRs than Northern Italy, except
for Piedmont and Puglia.
Figure 3 shows the regional distribution of SDRs by
gender. The regional variability proved to be statistically
significant for both males and females (males: Q-test =
638.5, p < 0.001; females: Q-test = 700.1, p < 0.001).
However, among men, we found a clear-cut divide in
SDR values between Central and Southern Italy; specific-
ally, in general 95% CIs of SDRs exceeded the nationalion to the Italian average (black line) for the years 2006–08.
ion to the Italian average (black line) for the years 2006–08.
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http://www.biomedcentral.com/1472-6963/12/310value in Southern regions, while in Northern and Cen-
tral regions were lower than the national average.
Among women, the regional variability proved to be
greater than among men, but 95% CIs of regional SDRs
did not reveal a clear-cut geographical pattern. Campania
had the highest gender-specific SDRs.
Cancer and cardiovascular diseases were the lead-
ing causes of amenable mortality (23.0 and 29.3 per
100,000) and accounted, respectively, for 36.5% and
49.0% of overall amenable mortality. Figure 4a, b
shows the radar plots of the regional SDRs compared withCampania
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Figure 5 a. Amenable mortality vs. life expectancy at birth (males) fo
b. Amenable mortality vs. life expectancy at birth (females) for the year 200the national average for these diseases. Though regional
SDRs for cancer exhibited a limited departure from the na-
tional average, regional SDRs for cardiovascular diseases
were above the mean in Southern Italy and below the
mean in Central and Northern Italy.
Convergent validity of the indicator
To investigate the convergent validity of amenable
mortality, we examined the association between
SDRs and some health indicators. We observed a
statistically significant negative correlation betweenAbruzzo
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Figure 6 a. Amenable mortality vs. disability-free life expectancy at age 15 (males). Data source: Indagine Istat su condizioni di salute e
ricorso ai servizi sanitari 2004–2005 [15]. b. Amenable mortality vs. disability-free life expectancy at age 15 (females). Data source: Indagine Istat su
condizioni di salute e ricorso ai servizi sanitari 2004–2005 [15].
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(male: r = −0.64, p = 0.002; female: r = −0.88, p <
0.001) (Figure 5a, b) [19] and between SDR and
disability-free life expectancy at age 15 (male: r =
−0.70, p < 0.001; female: r =−0.67, p < 0.001)
(Figure 6a, b). Furthermore, we found a statistically
significant inverse relationship between SDR and the
regional prevalence of cancer (r = −0.53; p = 0.013)
(Figure 7) and a non statistically significant negative correl-
ation between SDR and the prevalence of cardiovascular
diseases (r = −0.43; p = 0.051) (Figure 8).Relationship of amenable mortality with socioeconomic
indicators
When we examined the effect of socioeconomic and
resource-consumption indicators on SDRs, we found a
non statistically significant association between SDR and
public health spending per capita (r = −0.25; p = 0.267)
(Figure 9); however, we found a strong negative correl-
ation between SDR and GDP per capita (r = −0.69;
p < 0.001) (Figure 10) and between SDR and num-
ber of diagnostic and laboratory tests per 1,000 inha-
bitants (r = −0.52; p = 0.016) (Figure 11).
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Figure 7 Amenable mortality vs. cancer prevalence; cancer includes all types of malignant tumors. Data source: Indagine Istat su
condizioni di salute e ricorso ai servizi sanitari 2004–2005 [15].
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Evidence from the most recent studies indicates that
amenable mortality can be used to assess health-care
performance across countries over time. Italy showed
the third-lowest amenable mortality in 2005 among 31
OECD countries, indicating a good performance of
health-care services [11].
Our study shows that for the period 2006–08, the SDR
was 62.6 per 100,000 inhabitants, though there were re-
gional differences with a clear-cut divide being evidentPiedmont
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Figure 8 Amenable mortality vs. relative prevalence of cardiovascular
infarction, and angina pectoris. Data source: Indagine Istat su condizionibetween Central and Southern Italy. In Italy, disparities in
the geographical distribution have been documented for
educational level (percentage of the population with only
elementary education: 22.5% in the North and 27.2% in the
South) [20], income (family average net income: 37,440
euros in the North and 27,971 euros in the South) [21], and
poverty (incidence of relative poverty: 4.9% in the North
and 23.0% in the South) [22]. With regard to health-care
supply, Southern regions have a smaller number of hospital
beds, more private facilities, and a poorer endowment ofAosta Valley
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diseases, including stroke, hypertension, acute myocardial
di salute e ricorso ai servizi sanitari 2004–2005 [15].
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Figure 9 Amenable mortality vs. public health expenditure per capita for the year 2008. Data source: Rapporto Osservasalute 2011 [16].
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regions had 9 MRI scanners per million inhabitants in 2007
compared with 6.3 in Southern regions [23]. Our results
are consistent with evidence from the literature, suggest-
ing that the quality of care is better in Northern than in
Southern Italian regions in terms of percentage of inappro-
priate hospital admissions [24], proportion of surgical
interventions implemented within 48 hours of hospital ad-
mission for elderly patients with hip fractures [17,25], and
adherence to breast cancer screening programs [26].Abruzzo
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Figure 10 Amenable mortality vs. GDP per capita for the year 2008. DMoreover, the average SDR was lower in women
(mean, 59.1; range, 46.6–72.3 per 100,000) than in men
(mean, 66.0; range, 58.5–80.4 per 100,000). This may re-
sult from women’s higher life expectancy at birth and
gender-specific help-seeking patterns. The divergence in
SDR values between Central and Southern Italy was
more evident among men than in women. Pinkhasov
et al. [27] found different health-service utilization pat-
terns among males and females, with the latter showing
greater alacrity in accessing health-care services. ThesePiedmont
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Figure 11 Amenable mortality vs. number of diagnostic and laboratory tests per 1,000 inhabitants for the year 2008. Data source:
Ministero della Salute – Sistema Informativo Sanitario 2008 [17].
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ity, mortality, and life expectancy.
In our study, cancer and cardiovascular diseases
proved to be the leading causes of amenable mortality,
accounting for 85.5% of the overall indicators. A greater
regional variability was found for cardiovascular diseases
than for cancer. This finding may suggest that Nolte and
McKee’s list is especially sensitive to conditions for
which effective and appropriate health care is essential,
such as cardiovascular diseases.
The convergent validity of amenable mortality with
some health indicators was partially supported by a high
negative correlation between SDR and life expectancy at
birth and disability-free life expectancy at age 15 for
both genders.
Our study shows that amenable mortality is related to
GDP per capita, but not to health expenditure per
capita. A possible interpretation of this finding is that
SDR is influenced by organizational and care delivery
models and different priority settings—not by the
amount of dedicated resources. Recently, Nagy et al. [28]
also reported a positive association between amenable
mortality and deprivation status in both genders.
Several caveats should be noted in the use of amenable
mortality as an outcome indicator of health-system per-
formance. First, it is important to note that the
categorization of a condition as amenable is essentially
based on a judgment about the effectiveness of medical
interventions in treating different conditions and pre-
venting death [9]. Furthermore, the selection of causes
of death that are “amenable to health care” is time-
dependent: technological progress constantly increasesthe opportunities to prevent premature deaths through
secondary prevention and treatments. Therefore, the list
of causes of death that are amenable to health care
changes over time and needs to be regularly updated
[11]. However, our investigation was over a relatively
short period of time (2006–08), during which there was
probably no major change in this trend.
Moreover, we chose to use Nolte and McKee’s list of
causes of death amenable to health-care. Unlike Tobias
and Yeh’s list, Nolte and McKee’s list included among
death causes adverse events to patients during surgical
and medical care, which are strongly related to quality
of care. Last, Tobias and Yeh’s list included among
the death causes chronic obstructive pulmonary disease
(age >45 years), whose prognosis is more related to life-
style than to health care, and bladder and thyroid cancer,
where treatment and surgical interventions are moder-
ately effective.
Second, the prevalence of diseases whose deaths are
amenable to health-care may vary across regions. For in-
stance, if the prevalence of cancer is substantially higher in
one region, this region will need to devote more resources
to avoid deaths from this disease category [11]. To address
this issue, we analyzed the relationship between amenable
mortality and disease prevalence for cancer and cardiovas-
cular diseases. We found evidence that amenable mortality
displays a negative relationship with the prevalence of can-
cer. This may suggest that when this specific condition is
common, health services become more experienced and ef-
fective in treating the condition.
Third, health-service performance may depend on the
quantity of resources available to provide effective
Fantini et al. BMC Health Services Research 2012, 12:310 Page 11 of 12
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no relationship between SDR and per capita public health
expenditure.
Keeping these limitations in mind, the present study pro-
vides, in the context of decentralization of powers in health
care, an easily calculated, valid indicator for monitoring the
performance of health-care systems as a basis for evidence-
based policy decision making. This indicator could be use-
ful not only for a comparison between systems but also to
detect variations in a health-care system over time. And the
indicator could be a positive element in continuous efforts
to improve the policies, organization and quality in a
decentralized health-care system.
Conclusions
Our results highlight that, in line with other health-care
performance indicators, amenable mortality is lower in
North and Central regions of Italy than in Southern
regions. We argue that this indicator can be used to inform
policy decision-making processes in decentralized health-
care systems and monitor their effectiveness and equity.
Amenable mortality exhibits an inverse relationship with
life expectancy, prevalence of cancer and cardiovascular
diseases, and socioeconomic and resource consumption
indicators. Further investigation is warranted to analyze the
trend of SDRs at a subnational level over time.
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